Taking stock

The Tel Aviv-based Malenki Theater company is staging one-man show ‘Orpheus in the Metro,’ for second time.

August 13, 2014 17:51

The play is about an unnamed man who stalks women in the Paris subway system.. (photo credit: Courtesy)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


The Malenki Theater company doesn’t mess around. If you’re looking for light entertainment, something to pass an hour or two with some fun and mostly mindless offering, you’d best be looking elsewhere.

The troupe first set up for business in 1997, shortly after Igor Berezin, the company’s founder and director, made aliya from the former Soviet Union. Berezin took his first giant step for theatrical mankind when he decided that Malenki was going to work in Hebrew. That was despite the fact that the first bunch of actors were Russian speakers and that, at the time, Berezin himself had, at best, a sketchy command of Hebrew.


Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

Cookie Settings